Ethics and the Pharmaceutical Industry

by Michael A . Santoro (Author), ThomasM.Gorrie (Author)

New
Paperback
2007
$37.30

Despite the pharmaceutical industry's notable contributions to human progress, including the development of miracle drugs for treating cancer, AIDS, and heart disease, there is a growing tension between the industry and the public. Government officials and social critics have questioned whether the multibillion-dollar industry is fulfilling its social responsibilities. This doubt has been fueled by the national debate over drug pricing and affordable healthcare, and internationally by the battles against epidemic diseases, such as AIDS, in the developing world. Debates are raging over how the industry can and should be expected to act. The contributions in this book by leading figures in industry, government, NGOs, the medical community, and academia discuss and propose solutions to the ethical dilemmas of drug industry behavior. They examine such aspects as the role of intellectual property rights and patent protection, the moral and economic requisites of research and clinical trials, drug pricing, and marketing.

Synopsis

Despite the pharmaceutical industry's notable contributions to human progress, including the development of miracle drugs for treating cancer, AIDS, and heart disease, there is a growing tension between the industry and the public. Government officials and social critics have questioned whether the multibillion-dollar industry is fulfilling its social responsibilities. This doubt has been fueled by the national debate over drug pricing and affordable healthcare, and internationally by the battles against epidemic diseases, such as AIDS, in the developing world. Debates are raging over how the industry can and should be expected to act. The contributions in this book by leading figures in industry, government, NGOs, the medical community, and academia discuss and propose solutions to the ethical dilemmas of drug industry behavior. They examine such aspects as the role of intellectual property rights and patent protection, the moral and economic requisites of research and clinical trials, drug pricing, and marketing.

$37.30

Quantity

10 in stock

More Information

Format: Paperback
Pages: 528
Edition: 1
Publisher: Cambridge University Press
Published: 23 Jul 2007
ISBN 10: 0521708885
ISBN 13: 9780521708883

Media Reviews

'... Michael Santoro and Thomas Gorrie have compiled a series of essays that provide a fair, balanced and insightful examination of an increasingly troubled relationship between the pharmaceutical industry and society.' Journal of the American Medical Association

Author Bio

Michael A. Santoro is Associate Professor with tenure in the Business Environment Department at Rutgers Business School, where he teaches courses on business ethics, public policy, labor and human rights, law, ethical issues in the pharmaceutical industry, and China business strategy. Professor Santoro holds a PhD in Public Policy from Harvard University and a JD from the New York University School of Law. As a Research Associate at Harvard Business School, he wrote or co-authored nearly 30 case studies and teaching notes on ethical and legal topics such as global protection of intellectual property, insider trading, the Federal Sentencing Guidelines, and the Fair Credit Reporting Act. Professor Santoro has also published numerous journal articles, op-ed articles, and book chapters on these topics in publications such as Foreign Policy, and Human Rights Quarterly. He is the author of Profits and Principles: Global Capitalism and Human Rights in China (2000). Thomas M. Gorrie is Corporate Vice President, Government Affairs and Policy at Johnson and Johnson, with responsibility as Corporate Officer for all federal, state, and international government affairs and policy. He has over 30 years of worldwide health care experience. He has worked with various Johnson and Johnson companies in research and development, marketing and sales, business development, strategic planning, general management, international venture capital, and health policy. Dr Gorrie received his PhD in chemistry from Princeton University. He completed post-doctoral studies at the Swiss Federal Institute of Technology in Zurich. He serves on numerous non-profit boards, including Duke University Health Care System, Robert Wood Johnson University Hospital, the Dean Advisory Board of the Rutgers Business School, and the Hun School of Princeton.